drugset / Trial / NCT01118702

A Study to Explore Plasma Levels of CONCERTA, Ritalin-SR and Novo-Methylphenidate ER-C in Healthy Volunteers

NCT01118702

Phase 1 Completed 30 enrolled Janssen-Ortho Inc., Canada
RandomizedCrossoverOpen-labelBasic science

Summary

This is a study of blood plasma levels of methylphenidate in healthy volunteers over a 24 hour period after they take this medication.

Timeline

Start
2010-05
Primary completion
Completion
2010-06

Drugs

EvaluationDrugModalityDoseRoute
Comparator Methylphenidate Small molecule 54 mg Oral
Comparator Methylphenidate Small molecule 60 mg Oral

Indications

No indication recorded.